title: Gemcitabine-Associated Thrombotic Microangiopathy: Response to Complement Inhibition and Reinitiation of Gemcitabine.
authors.affiliation: Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.
authors.forename: Jeffrey L
authors.initials: JL
authors.lastname: Turner
authors.affiliation: Department of Pharmacy, The James Comprehensive Cancer Center at The Ohio State University, Columbus, OH.
authors.forename: Joshua
authors.initials: J
authors.lastname: Reardon
authors.affiliation: Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ.
authors.forename: Tanios
authors.initials: T
authors.lastname: Bekaii-Saab
authors.affiliation: Division of Hematology, Department of Medicine, The James Comprehensive Cancer Center at The Ohio State University, Columbus, OH.
authors.forename: Spero R
authors.initials: SR
authors.lastname: Cataland
authors.affiliation: Department of Pharmacy, The James Comprehensive Cancer Center at The Ohio State University, Columbus, OH. Electronic address: matthew.arango@osumc.edu.
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Arango
keywords: Drug-induced thrombotic microangiopathy; Eculizumab; Hemolytic uremic syndrome; Pancreatic cancer; Toxicity